Catharina Willemien Menke-van der Houven van Oordt - Amsterdam University Medical Center

基本信息

Career Trajectory

Bio

My ultimate goal as an oncologist is to have effective cancer treatment for every individual patient. Our research efforts concentrate on PET imaging as part of early drug development and for patient selection as well as treatment evaluation. In the clinic I treat patients with breast cancer, endocrine tumors and patients who want to participate in phase I trials.

Research Interests

Papers共 171 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

The Diagnostic Accuracy of 18F-FDG PET and 18F-FES PET for Staging Grade 1-2 Estrogen Receptor-Positive Breast Cancer

Jelijn J Knip,Ramsha Iqbal, Emma C Bonjer, Lemonitsa H Mammatas, Annette A van Zweeden, Paola Perin, Jaap J M Teunissen, Gwen M P Diepenhorst, Laura J Schijf, Sandra D Bakker, Noortje Schoenmakers, Susanne van der Velde, Ellis Barbé, Katya Duvivier, Inge R Konings, Gerben J C Zwezerijnen,Albert D Windhorst,Ronald Boellaard, Daniela E Oprea-Lager,C Willemien Menke-van der Houven van Oordt

Radiologyno. 3 (2025): e241850-e241850

Cited0Views0WOSBibtex

Intrapatient 16Α-[18F]fluoro-17β-estradiol PET Heterogeneity As a Prognostic Factor for Endocrine Therapy Response and Survival in Patients with Estrogen Receptor-Positive Metastatic Breast Cancer

Jasper J L van Geel, Jasmine Moustaquim,Jorianne Boers, Sjoerd G Elias, M, Jelijn J Knip, Andor W J M Glaudemans, Erik F J de Vries, Geke A P Hospers,Michel van Kruchten,Marcel Stokkel, Daniela E Oprea-Lager,Willemien C Menke-van der Houven van Oordt, Elisabeth G E de Vries,Carolina P Schröder, IMPACT-Metastatic Breast Consortium

Journal of nuclear medicine official publication, Society of Nuclear Medicineno. 2 (2025): 194-200

Cited0Views0WOSBibtex

Integrating Molecular Imaging and Transcriptomic Profiling in Advanced HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine: an Analysis of the ZEPHIR Clinical Trial

Mattia Rediti,Danai Fimereli,Magdalena Mileva,Zena Wimana,David Venet,Patrick Flamen,Thomas Guiot,Elisabeth G. E. de Vries,Carolien P. Schroder,Catharina Willemien van der Houven van Oordt,Marion Maetens,Samira Majjaj,Denis Larsimont,Francoise Rothe,Christos Sotiriou,Geraldine Gebhart

CLINICAL CANCER RESEARCHno. 1 (2025): 110-121

Cited0Views0WOSBibtex

Drug Release from Docetaxel-Entrapped Core-Crosslinked Polymeric Micelles: A Population Pharmacokinetic Modelling Approach Based on Clinical Data

Pascale C S Rietveld,Stijn L W Koolen, Stefan Zeiser,Cristianne J F Rijcken, Martijn van Noort, Ruben A G van Eerden, Florence Atrafi, Iris H C Miedema,C Willemien Menke-van der Houven van Oordt,Birgit C P Koch, Ron H J Mathijssen,Nelleke Snelder, Sebastiaan D T Sassen

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie (2025): 118028-118028

Cited0Views0WOSBibtex

Validating Image-Derived Input Functions of Dynamic 18F-FDG Long Axial Field-of-view PET/CT Studies

Charlotte L C Smith, Gerben J C Zwezerijnen,Marijke E den Hollander, Henricus N J M Greuter, Nienke R Gerards, Josée Zijlstra,C Willemien Menke-van der Houven van Oordt,Idris Bahce,Maqsood Yaqub,Ronald Boellaard

Frontiers in nuclear medicine (2025): 1556848-1556848

Cited0Views0WOSBibtex

Spectral Analysis of Dynamic Large Axial Field of View PET/CT Studies

Ronald Boellaard, Charlotte Smith,Gerben Zwezerijnen,Marijke den Hollander,Nelleke Tolboom,Denise Visser,Idris Bahce,Catharina Menke-van der Houven van Oordt,Josee Zijlstra,Sandeep Golla,Maqsood Yaqub

JOURNAL OF NUCLEAR MEDICINE (2024)

Cited0Views0Bibtex

Non-specific Irreversible 89Zr-Mab Uptake in Tumours: Evidence from Biopsy-Proven Target-Negative Tumours Using 89Zr-Immuno-pet

Jessica E. Wijngaarden,Yvonne W. S. Jauw,Gerben J. C. Zwezerijnen,Berlinda J. de Wit-van der Veen,Daniëlle J. Vugts,Josée M. Zijlstra,Guus A. M. S. van Dongen,Ronald Boellaard,C. Willemien Menke-van der Houven van Oordt,Marc C. Huisman

EJNMMI Researchno. 1 (2024)

Cited0Views0WOSBibtex

338Tip EORTC-2129-BCG: Elacestrant for Treating ER+/HER2- Breast Cancer Patients with Ctdna Relapse (TREAT Ctdna)

M. Ignatiadis,E. Saloustros,A. Joaquim, J.G. Casas, C.M. Kelly,E. Razis, M. Lambertini,T. Foukakis, M. Fehr,C.W. Menke-van der Houven van Oordt, T. Antoniolli Crestani,S. Pernas Simon, B. Bussels, M. Hanssens, P. Neven,E. Xenophontos, T. Meyskens, F.C. Bidard, C. Poncet, W. Janni

Annals of Oncology (2024): S355-S356

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn